Pharmosutical Companies Aren't Partnering With the Medicines Patent Pool

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Companies are not interested in partnering with groups trying to help build more manufacturing processes elsewhere. One of them is, they say there are fears about quality control. Another issue is there could be shortages and supplies that would make it difficult to have more manufacturers step in. They also say it's very complex to make these products.

Less than 1% of those in low income countries are fully vaccinated, and that number only rises to 10% in low-middle income countries. Meanwhile more than half of the population in wealthier countries have received a double dose with several now rolling out third dosess.

In this episode of Coronapod we look at the role of pharmaceutical manufacturers. Drug companies are facing increased pressure to partner with manufacturing firms in the global south but most are reluctant to relinquish control. We ask what needs to change to help address the global disparity in vaccine access.

News: The fight to manufacture COVID vaccines in lower-income countries

Hosted on Acast. See acast.com/privacy for more information.